No Consumer Sale: We do not entertain retail inquiries or direct sales to patients
Manufacturing Scale Is Becoming a Competitive Advantage: Supply constraints have exposed production limitations, driving major investment in large-scale GLP-1 manufacturing
"Addressing even one crore patients translates to a Rs 3,0004,000 crore opportunity," he says, "but the market will only expand meaningfully at lower price points, especially beyond metros." He expects the GLP-1 category to surpass Rs 2,000 crore within a year, led by generics driving down entry barriers
The blend is designed to support your skins natural moisture balance and elasticity, helping to create a smoother, more resilient-looking complexion that feels comfortable from morning to night
GLP-1 medications are only available with a prescription from a qualified healthcare provider